A. Glycopyrrolate/vilanterol B. Glycopyrrolate/indacaterol C. Aclidinium/indacaterol D. Ipratropium/albuterol

A. Glycopyrrolate B. Aclidinium C. Umeclidinium D. Tiotropium

A. They should not be used in patients with oral thrush. B. They should not be used in patients with suboptimal inspiratory flow. C. They are not useful for treatments with small particle size. D. They are difficult for patients with low cognition.

A. Provide the patient with the leaflet that comes with the treatment, as it is typically very detailed. B. Educate multiple patients in a group setting to save time. C. Demonstrate inhaler use, and then send the patient home with the leaflet that comes with the treatment. D. Have a one-on-one session with the patient, in which the technique is demonstrated to them and the patient then replicates the demonstration.

A. Ensure that all patients with COPD have received their influenza and pneumococcal immunizations. B. Ensure that patients with COPD only receive the pneumococcal conjugate vaccine. C. Ensure that patients with COPD only receive the pneumococcal polysaccharide vaccine. D. During the immunization visit, do not discuss other aspects of COPD care, as the patient may become overwhelmed